Metamark's Cambridge Lab Receives CAP Accreditation | GenomeWeb

NEW YORK (GenomeWeb) – Metamark today announced that its Cambridge, Mass., laboratory has received accreditation from the College of American Pathologists.

The lab will be the primary facility for processing the company's ProMark protein-biopsy test to aid physicians and prostate cancer patients select the most appropriate treatment options. The test generates a score and is targeted to the 85 percent of patients with biopsy Gleason grades of 3+3 or 3+4 for whom current standard-of-care tests may offer unclear guidance, the Cambridge-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.